Beyond Air
Sector: Healthcare & Life Sciences
About Beyond Air
Pulmonary hypertension treatment, harness the power of nitric oxide, with a focus on care.
Products
LungFit® GO; LungFit® PRO; LungFit® MAX
For treatment of Term and near-term neonates with hypoxic respiratory failure, commonly referred to as persistent pulmonary hypertension of the newborn (PPHN) Community-acquired viral pneumonia (including COVID-19) and bronchiolitis Nontuberculous mycobacteria (NTM) lung infection and in patients with underlying chronic obstructive pulmonary disease (COPD), suffering from persistent lung infections iNO concentration Low-concentration iNO: ≤80 ppm High-concentration iNO: 80 to 400 ppm High-concentration iNO: 80 to 400 ppm